Please try another search
PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It offers workflow navigation services; automated sample preparation extraction kits; IntelliPlex platform that is designed for pCode technology with for sample-to-answer multiplexing assays; oncology kits for lung cancer and mutation detection, as well as rearrangements; IntelliPlex SARS-CoV-2 detection test kits/flu kits and IntelliPlex SARS-CoV-2 variant analysis kits; and pCode coupling buffer sets. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Guo-Liang Yu | 60 | - | Independent Director |
Ter-Fung Tsao | 77 | - | Independent Director |
Yasuhiro Ohashi | - | 2020 | Representative Director |
I-Chun Lai | - | - | Independent Director |
Rimiru Hayashida | - | 2020 | Representative Director |
Dean Tsao | - | - | Chairman, President & CEO |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review